Adam Cheifetz
BIDMC
Appearances
- DateMay 8, 2023BACKGROUND: The impact of pregnancy on vedolizumab (VDZ) and ustekinumab (UST) pharmacokinetics is not well defined. Similarly, the time to infant clearance and outcomes following in-utero exposure require elucidation…
- DateMay 9, 2023Background: Patients with inflammatory bowel disease (IBD) often modify their diet in attempt to manage their disease and symptoms. In some cases, dietary changes involve excessive restriction, which may place patients at risk for adverse consequences…
Speakers
Beth Israel Deaconess Medical CenterBIDMCPresenter
- DateMay 9, 2023Background: Patients with inflammatory bowel disease (IBD) often modify their diet in attempt to manage their disease and symptoms. In some cases, dietary changes involve excessive restriction, which may place patients at risk for adverse consequences…
Speakers
Beth Israel Deaconess Medical CenterBIDMCPresenters
- DateMay 19, 2024
Presenter
BIDMC - DateMay 19, 2024
Presenters
University of Chicago Division of the Biological SciencesBIDMCIcahn School of Medicine Mount Sinai HospitalCleveland Clinic - DateMay 4, 2025This session will examine state of the art technological advances including wearable devices, intestinal ultrasound, and artificial intelligence based endoscopic assessment for determination of IBD activity…
Moderators
Cedars-Sinai Medical CenterBIDMC